You have 9 free searches left this month | for more free features.

Condition

Locally Advanced or Metastatic Solid Tumor (2)

Breast Adenocarcinoma (1)

Breast Cancer (1)

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast (1)

Recurrent Breast Carcinoma (1)

Stage IV Breast Cancer (1)

Overall Status

Active, not recruiting (2)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (2)

phase 1 (1)

Sponsor

Deciphera Pharmaceuticals LLC (2)

Montefiore Medical Center (1)

Collaborator

Albert Einstein College of Medicine (1)

Deciphera Pharmaceuticals LLC (1)

Intervention

rebastinib (3)

paclitaxel (2)

carboplatin (1)

eribulin mesylate (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

rebastinib

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Breast Cancer, Breast Adenocarcinoma, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Bronx (Rebastinib,

Terminated

Breast Cancer
+4 more

Rebastinib
+2 more

Bronx, New York

Montefiore Medical Center

Mar 23, 2022

Locally Advanced or Metastatic Solid Tumor Trial in United States (rebastinib, Carboplatin)

Active, not recruiting

Locally Advanced or Metastatic Solid Tumor

rebastinib
Carboplatin

San Francisco, California
+8 more

Aug 10, 2021

Locally Advanced or Metastatic Solid Tumor Trial in United States (rebastinib, Paclitaxel)

Active, not recruiting

Locally Advanced or Metastatic Solid Tumor

rebastinib
Paclitaxel

Birmingham, Alabama
+13 more

Sep 29, 2021